These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6389491)

  • 1. Double blind crossover randomised study of bromhexine in chronic obstructive airway disease.
    Misra MP; Tiwari UC; Chaubal CC; Galhotra R
    J Assoc Physicians India; 1984 May; 32(5):423-5. PubMed ID: 6389491
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

  • 5. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial.
    Valenti S; Marenco G
    Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on Lasolvan in chronic obstructive pulmonary disease.
    Král B; Ellás J; Rozánek P; Jirkal J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):601-6. PubMed ID: 7051260
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Bisolvon in chronic respiratory disease.
    Watson EW
    Med J Aust; 1974 Nov; 2(22):824-5. PubMed ID: 4456160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bromhexine in the prevention of postoperative complications in digestive surgery].
    Lobello R; Marzano LA; Corcione F; La Manna S; Cristinzio G; De Ascentis G; Scarafile P
    Minerva Chir; 1983 Oct; 38(20):1729-31. PubMed ID: 6664579
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the removal of inhaled particles from the lungs by voluntary coughing.
    Camner P
    Chest; 1981 Dec; 80(6 Suppl):824-7. PubMed ID: 7030658
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in immunoglobulins in the sputum and serum after the use of secretolytics in patients with chronic obstructive pulmonary disease].
    Prazić B; Acketa M; Obradović-Andelić S; Volf-Pavlović E
    Plucne Bolesti; 1985; 37(3-4):178-82. PubMed ID: 3836422
    [No Abstract]   [Full Text] [Related]  

  • 14. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: "Bisolvon" in chronic respiratory disease.
    Watson EW
    Med J Aust; 1974 Feb; 1(5):152. PubMed ID: 4818003
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.